Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.

The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...

Breathing is something most of us never think about — until suddenly, you can’t do it the way you normally do. Difficulty breathing can come on gradually, such as during ...

Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused ...

When it comes to the world of hot tools, a Dyson is basically the equivalent of a Rolex: luxurious, sleekly designed, and ...

We look forward to presenting important new data for Afrezza at this year’s ATTD and contributing to the scientific dialogue around meal-time diabetes management across both adult and pediatric ...

Nearly one million Israelis live with chronic lung diseases such as asthma and COPD, and for them the current security ...

Aptar Pharma and COVIRIX Medical collaborate to assess feasibility of adapting Aptar Pharma’s proprietary DPI platform for antiviral delivery.

When Charlamagne requested Curtis “apologize to black people” directly to the camera, Curtis told viewers she does “not condone” the slur — and asked those praising her language to not use her as a ...

Carla Bellucci, who became infamous after faking depression to get a free NHS nose job in 2019, has been diagnosed with COPD, an incurable lung condition affecting 1.4 million people in the UK ...

Hello, dear readers! Welcome to the monthly letters column. You have been sending us some very interesting mail, so we will dive right in.

Carla Bellucci has been diagnosed with a life-long lung condition and is now relying on the NHS to keep her alive and here ...